Compare Direxion Daily CSI China Internet Bull 2X Shares (CWEB) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily CSI China Internet Bull 2X Shares vs Invesco Ltd. — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.25 (market cap $176.60M), while Invesco Ltd. trades at $30.09 (market cap $13.47B). The key difference: Invesco Ltd. is far larger — about 76.3× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and Invesco Ltd. pays a 2.82% dividend while Direxion Daily CSI China Internet Bull 2X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and Invesco Ltd. for 77 Days on average.
| CWEB | IVZ | |
|---|---|---|
Market Cap | $176.60M | $13.47B |
Volume | 440,349 | 4,447,526 |
Sector | Leveraged / Inverse | Financials |
52-Week High | $55.62 | $33.31 |
52-Week Low | $17.39 | $22.44 |
Typical Hold Time | 24 Days | 77 Days |
Enterprise Value | — | $23.63B |
Dividend Yield | — | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CWEB trades at $18.02, down 1.85% today amid bearish technical signals. The stock shows weak momentum with all 13 moving averages signaling sell, though oscillators are neutral. Recent news highlights China's AI ambitions and potential for China growth stocks to surge, providing thematic catalysts. Financial ratios remain undisclosed in current data.
Outlook hinges on China's tech sector recovery and AI growth narrative. Risks include geopolitical tensions and market volatility. The upcoming dividend of $0.07 in September 2026 offers income potential, but investors need clarity on fundamentals for sustained upside.
Invesco (IVZ) trades at $30.09, down 0.95% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $281.70 million for 2025 despite revenue growth to $6.38 billion, with a negative net margin of -0.93%. Recent earnings have been mixed, beating in Q4 2025 and Q2 2026 but missing in Q1 2026, while Q3 2026 results are pending. Positive developments include strong operating cash flow of $1.53 billion in 2025 and the expansion of its QQQ ETF suite.
The outlook is cautiously optimistic, supported by a consensus price target of $33.71 and no sell ratings among analysts. Key opportunities lie in continued AUM growth and ETF innovation, but risks include profitability challenges and market volatility. The stock's current price near support at $30.00 suggests limited downside if fundamentals improve with upcoming earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Direxion Daily CSI China Internet Bull 2X Shares
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
